Regulatory Interlinx, Inc. is well placed to provide expert CMC regulatory consulting services to the pharmaceutical industry. Dr. Sally Look (president) is a natural products chemist who received her doctorate from the University of California, San Diego (UCSD), Scripps Institution of Oceanography, and went on to hold research positions at Columbia University, UCSD and the Frederick Cancer Research Facility.
From academia, Dr. Look was recruited to the pharmaceutical industry as a chemist, where she worked as a spectroscopist. Her work in industry, along with her diverse research experience, led to a position as a reviewing chemist at the FDA Center for Drug Evaluation and Research (CDER) Division of Oncology and Pulmonary Drug Products. In this position, Dr. Look gained invaluable insight into the workings of the FDA, the industry's perspective on drug development and regulatory affairs.
Dr. Look left FDA in 1993 to become a regulatory consultant to serve the pharmaceutical industry. Regulatory Interlinx, Inc. was established in 1996 to support the growing demand for Dr. Look's regulatory consulting services. Dr. Look's extensive experience in academia, government and industry has enabled her to bring a unique and successful blend of expertise to regulatory affairs. Regulatory Interlinx now serves a broad clientele that includes companies of all sizes, ranging from small start-up biopharmaceutical firms to major multi-national and foreign corporations. Regulatory Interlinx has developed a large network of regulatory and compliance professionals to meet diverse client needs, while maintaining a focus on quality and personalized service.